{"name":"mohamed bouchoucha","slug":"mohamed-bouchoucha","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"metronidazole based quadriple therapy","genericName":"metronidazole based quadriple therapy","slug":"metronidazole-based-quadriple-therapy","indication":"Helicobacter pylori infection eradication in peptic ulcer disease","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"placebo based quadriple therapy","genericName":"placebo based quadriple therapy","slug":"placebo-based-quadriple-therapy","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"metronidazole based quadriple therapy","genericName":"metronidazole based quadriple therapy","slug":"metronidazole-based-quadriple-therapy","phase":"marketed","mechanism":"Metronidazole-based quadruple therapy combines metronidazole with three other agents (typically a proton pump inhibitor, bismuth compound, and tetracycline or clarithromycin) to eradicate Helicobacter pylori through multiple antimicrobial and acid-suppressive mechanisms.","indications":["Helicobacter pylori infection eradication in peptic ulcer disease","H. pylori-associated chronic gastritis"],"catalyst":""},{"name":"placebo based quadriple therapy","genericName":"placebo based quadriple therapy","slug":"placebo-based-quadriple-therapy","phase":"marketed","mechanism":"A placebo-based quadruple therapy that relies on the placebo effect across four treatment components to produce therapeutic benefit.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}